These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31133497)

  • 1. Association of serum proprotein convertase subtilisin/kexin type 9 with early atherosclerosis in newly diagnosed type 2 diabetes mellitus.
    Guo W; Gong Y; Li J; Qin P; Lu J; Li X; Zhu W; Xu N; Zhou H; Zhang Q
    Nutr Metab Cardiovasc Dis; 2019 Aug; 29(8):815-821. PubMed ID: 31133497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Proprotein Convertase Subtilisin Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic Adults.
    Chan DC; Pang J; McQuillan BM; Hung J; Beilby JP; Barrett PH; Watts GF
    Heart Lung Circ; 2016 May; 25(5):520-5. PubMed ID: 26706651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes.
    Yoo HJ; Hwang SY; Hong HC; Choi HY; Yang SJ; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH
    Cardiovasc Diabetol; 2011 Nov; 10():103. PubMed ID: 22108456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis.
    Ferraz-Amaro I; López-Mejías R; Ubilla B; Genre F; Tejera-Segura B; de Vera-González AM; González-Rivero AF; Olmos JM; Hernández JL; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2016; 34(6):1013-1019. PubMed ID: 27606890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients.
    Nekaies Y; Baudin B; Kelbousi S; Sakly M; Attia N
    J Diabetes Complications; 2015; 29(8):1165-70. PubMed ID: 26412029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between carotid intima-media thickness and carotid artery stiffness assessed by ultrafast ultrasound imaging in patients with type 2 diabetes.
    Pan FS; Xu M; Yu L; Luo J; Li MY; Liang JY; Zheng YL; Xie XY
    Eur J Radiol; 2019 Feb; 111():34-40. PubMed ID: 30691662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proprotein convertase subtilisin/Kexin type 9 and vascular disease in type 2 diabetic patients.
    Armentaro G; Carbone F; Cassano V; Liberale L; Minetti S; Bertolotto MB; Mannino G; Fiorentino TV; Perticone M; Succurro E; Sesti G; Montecucco F; Andreozzi F; Sciacqua A
    Eur J Clin Invest; 2023 Mar; 53(3):e13900. PubMed ID: 36346620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.
    Cao YX; Liu HH; Sun D; Jin JL; Xu RX; Guo YL; Wu NQ; Zhu CG; Li S; Zhang Y; Sun J; Li JJ
    Atherosclerosis; 2018 Oct; 277():7-14. PubMed ID: 30170223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of PCSK9 levels with indices of vascular function and subclinical atherosclerosis in patients with familial dyslipidemias.
    Vlachopoulos C; Koutagiar I; Terentes-Printzios D; Skoumas I; Rigatou A; Miliou A; Skliros AN; Pantou S; Filis K; Tousoulis D
    Hellenic J Cardiol; 2019; 60(2):124-128. PubMed ID: 29807195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elevated level of serum PCSK9 in patients with systemic lupus erythematosus].
    Fang C; Luo T; Chen X; Lin L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jun; 34(6):541-545. PubMed ID: 30236208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma miR-146a levels are associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus.
    Guo W; Li XN; Li J; Lu J; Wu J; Zhu WF; Qin P; Xu NZ; Zhang Q
    J Diabetes Complications; 2020 Dec; 34(12):107725. PubMed ID: 32981813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention.
    Zhu YM; Anderson TJ; Sikdar K; Fung M; McQueen MJ; Lonn EM; Verma S
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2254-9. PubMed ID: 26293463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease.
    Aydogan Baykara R; Yilmaz PD; Göktepe MH; Kadiyoran C; Ogul M; Kucuk A; Cumhur Cüre M; Cüre E
    Clin Exp Hypertens; 2022 Jul; 44(5):480-486. PubMed ID: 35502687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients.
    Kundi H; Kiziltunc E; Ates I; Cetin M; Barca AN; Ozkayar N; Ornek E
    Endocr Res; 2017 Feb; 42(1):36-41. PubMed ID: 27111290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population.
    Guo W; Gong Y; Gu Y; Fu Z; Fan H; Gao B; Zhu X; Fu J; Zhao Y; Sun M; Liu X; Jiang XC; Yang T; Zhou H
    Lipids Health Dis; 2018 Jan; 17(1):15. PubMed ID: 29343301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.
    El Khoury P; Roussel R; Fumeron F; Abou-Khalil Y; Velho G; Mohammedi K; Jacob MP; Steg PG; Potier L; Ghaleb Y; Elbitar S; Ragot S; Andreata F; Caligiuri G; Hadjadj S; Boileau C; Marre M; Abifadel M; Varret M; Hansel B
    Diabetes Obes Metab; 2018 Apr; 20(4):943-953. PubMed ID: 29205760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.
    Yang SH; Li S; Zhang Y; Xu RX; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Cui CJ; Dong Q; Sun J; Li JJ
    J Endocrinol Invest; 2016 Aug; 39(8):875-83. PubMed ID: 26894681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.
    Shi J; Zhang W; Niu Y; Lin N; Li X; Zhang H; Hu R; Ning G; Fan J; Qin L; Su Q; Yang Z
    Cardiovasc Diabetol; 2020 Dec; 19(1):209. PubMed ID: 33302966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study.
    Ruscica M; Ferri N; Fogacci F; Rosticci M; Botta M; Marchiano S; Magni P; D'Addato S; Giovannini M; Borghi C; Cicero AFG;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28468788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.